2008
DOI: 10.1186/1471-2407-8-91
|View full text |Cite
|
Sign up to set email alerts
|

The development and deployment of Common Data Elements for tissue banks for translational research in cancer – An emerging standard based approach for the Mesothelioma Virtual Tissue Bank

Abstract: Background: Recent advances in genomics, proteomics, and the increasing demands for biomarker validation studies have catalyzed changes in the landscape of cancer research, fueling the development of tissue banks for translational research. A result of this transformation is the need for sufficient quantities of clinically annotated and well-characterized biospecimens to support the growing needs of the cancer research community. Clinical annotation allows samples to be better matched to the research question … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
40
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 45 publications
(41 citation statements)
references
References 10 publications
1
40
0
Order By: Relevance
“…Similarly, Office of Management and Budget (OMB) and de facto standards for patient characteristics (e.g., race, ethnicity, and demographics) will be applied, with the goal of limiting unnecessary variations of questions that have relevance across all rare disease registries. New and forthcoming pilot projects sponsored by HL7, caBIG, and CDISC that demonstrate the use of common data elements and shared conceptual domain models for specific therapeutic areas (e.g., cardiovascular, tuberculosis, and diabetes) will also be monitored and explored as a source of standardized questions that could be incorporated into the library and re-used for rare disease registry data collection (Gao, Zhang, Xie, Zhang, & Hu, 2006; Mohanty, et al, 2008; Winget, et al, 2003). Standardized health data from CDC’s PHIN Shared Vocabulary will be searched for value sets standardized for a variety of use cases.…”
Section: Relevant Standardsmentioning
confidence: 99%
“…Similarly, Office of Management and Budget (OMB) and de facto standards for patient characteristics (e.g., race, ethnicity, and demographics) will be applied, with the goal of limiting unnecessary variations of questions that have relevance across all rare disease registries. New and forthcoming pilot projects sponsored by HL7, caBIG, and CDISC that demonstrate the use of common data elements and shared conceptual domain models for specific therapeutic areas (e.g., cardiovascular, tuberculosis, and diabetes) will also be monitored and explored as a source of standardized questions that could be incorporated into the library and re-used for rare disease registry data collection (Gao, Zhang, Xie, Zhang, & Hu, 2006; Mohanty, et al, 2008; Winget, et al, 2003). Standardized health data from CDC’s PHIN Shared Vocabulary will be searched for value sets standardized for a variety of use cases.…”
Section: Relevant Standardsmentioning
confidence: 99%
“…Three papers focus on the need to standardize data collection by applying common data elements. [88][89][90] Seven papers 27,40,49,[91][92][93][94] highlight the challenges associated with collecting and analyzing data from multiple sites and informatics platforms, such as the differences in the data collected for clinical use versus research use, 27 variances between the functionality of different EHRs, 91 lack of standardization in how data are reported among multiple data sources, 40,49,92,93 and difficulty in implementing standardization efforts after systems are operational. 94…”
Section: Emerging Themes the Need For Standardizationmentioning
confidence: 99%
“…There are few resources for methodology of CDE development. [45][46][47] One CDE project that is specifically focused on diabetes at the point of capture (i.e., EHR) is the Diabetes Data Strategy (Diabe-DS) demonstration project. 48,49 The project was formed in early 2009 in the HL7 EHR Working Group (with representatives from academia, professional societies, government, EHR developers, and pharmaceutical industry) to develop a repeatable process that identifies important data elements for clinical care and secondary use.…”
Section: Content Standards: Important "Common" Diabetes Data Elementsmentioning
confidence: 99%